PDF下载 ( 158 KB)
Diagnosis and treatment of intrahepatic cholestasis
-
摘要:
<正>肝内胆汁淤积症是由多种原因引起肝细胞和(或)毛细胆管胆汁分泌障碍,导致部分或完全性胆汁流阻滞为特征的综合征。应注意与肝外阻塞性黄疸类相鉴别,二者均表现为重度黄疸、皮肤瘙痒、大
-
[1]Andreas G, , Martin W, Christoph G, et al.Principles of hepatic or-ganic anion transporter regulation during cholestasis, inflammation and liver regeneration[J].Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, 2007, 1773 (3) ∶283-308. [2]Hoekstra H, Tian YH.Complete dearterialization of the liver causes intrahepatic cholestasis due to reduced hepatobiliary transporter ex-pression.[J].Liver Transplantation, 2007, 13 (6) ∶105-105. [3]Yang H, Plosch T, Lisman T, et al.Inflammation mediated Down-regulation of hepatobiliary transporters contributes to intrahepatic cho-lestasis and liver damage in murine biliary atresia[J].PediatricRe-searct, 2009, 66 (4) ∶380-385. [4]Trauner M, Ficker P, Wagner M.MDR3 (ABCB4) defects:a paradigm for the genetics of adult cholestatic syndromes[J].Semin Liver Dis, 2007, 27∶77-98. [5]苏先狮.胆汁淤积性黄疸的诊断和治疗[J].临床肝胆病杂志, 2005, 21 (3) ∶137-138. [6]茅益民, 曾民德.药物性肝损害的诊治[J].药品评价, 2007, 4 (6) ∶389. [7] 李瑞, 陈佑江, 文明波.胆汁淤积性肝炎[J].器官移植内科学杂志, 2008, 3 (3) ∶155. [8]Heathcote E.The alner ican association for the study of liver diseases practice guidelines[J].Hepatology, 2000, 31∶1005-1013. [9]Kadokawa Y, Omagari K Hazama H, et al.Evaluation of newly de-veloped ELASA“MESACUP-2test mitochondrial M2”kit for the diagnosis of primary biliary cirhosis[J].Clin Biochem, 2003, 36 (3) ∶203-210. [10]Geenes V, Williamson C.Intrahepatic cholestasis of pregnancy[J].World Journal Of Gastroentetology, 2009, 15 (17) ∶2049-2066. [11]Sentilhes L, BacqY.Intrahepatic cholestasis of pregnancy[J].Jour-nal De Gynecologie Obstetrique Et Blologie De La Reproduction, 2008, 37 (2) ∶118-126. [12]M fillenbach R, Bennett A, Tetlow N, et al.ATP8B1mutations in British cases with intrahepatic cholestasis of Pregnancy[J].Gut, 2005, 54 (6) ∶829-834. [13]Harris MJ, LE Couteur DG, Arias IM.Progressive familial intrahe-patic cholestasis:genetic disorders of biliary transporters[J].Gastro-enterol Hepatol, 2005, 20 (6) ∶807-817. [14]Nagasaka H, Yorifuji T, Egawa H, et al.Evaluation of risk for ath-erosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis:two congenital cholestatic diseases with different lipopro-teinmetabolisms[J].J Pediatr, 2005, 146 (3) ∶329-335. [15]Bellmann R, Feistritzer C, Zoller H, et al.Treatment Of intractable pruritus in drug induced cholestasis with albu-min dialysis:a report of two cases[J].Amercian Society of Artificial Internal Organs, 2004, 50 (4) ∶387-391. [16]Talwalkar JA, Souto E, Jorgensen RA, et a1.Natural history ofpruri-tus in primary biliary cirrhosis[J].Clin Gastroenterol Hepatol, 2003, 1 (4) ∶297-302. [17]Corpechot C.Carrat F, Bonnand A, et al.An effect of ursode-oxyeh0heacid therapy on liver fibrosis progression in primary biliary cirrhosis[J].Hepatology, 2000, 32 (12) ∶1196-1199. [18]E.Jenny H, Karen CD, Valery W, et al.Canadian muhieenter double-blind randomized controlled trial0f ursed eoxycholic acid in primary biliary cirrhosis[J].Hepatology, 1994, 19 (5) :1149-1156. [19]Roll O, Kirsten M, Boberg M, et al.Hish-dose ursodeoxyehohe acid in primary sclerosing cholangitis:a5-year multicenter, random-ized, controlled study[J].Gastroenterology, 2005, 129 (11) ∶1464-1472. [20]沈镭, 陆伦根.腺苷蛋氨酸在胆汁淤积性肝病治疗中的应用[J].胃肠病学, 2006, 11 (3) ∶190-191. [21]Péerez Fernández F, López Serrano P, Tomás E, et al.Diagnostic and therapeutic approach to cholestatic liver disease[J].Rev Esp En-ferm Dig, 2004, 96 (1) ∶60-73. -
本文二维码
计量
- 文章访问数: 1862
- HTML全文浏览量: 7
- PDF下载量: 1094
- 被引次数: 0
下载:
